These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

451 related items for PubMed ID: 22745483

  • 21. Discriminating between cellular and misfolded prion protein by using affinity to 9-aminoacridine compounds.
    Phuan PW, Zorn JA, Safar J, Giles K, Prusiner SB, Cohen FE, May BCH.
    J Gen Virol; 2007 Apr; 88(Pt 4):1392-1401. PubMed ID: 17374787
    [Abstract] [Full Text] [Related]

  • 22. Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice.
    Pfeifer A, Eigenbrod S, Al-Khadra S, Hofmann A, Mitteregger G, Moser M, Bertsch U, Kretzschmar H.
    J Clin Invest; 2006 Dec; 116(12):3204-10. PubMed ID: 17143329
    [Abstract] [Full Text] [Related]

  • 23. Neurometals in the Pathogenesis of Prion Diseases.
    Kawahara M, Kato-Negishi M, Tanaka KI.
    Int J Mol Sci; 2021 Jan 28; 22(3):. PubMed ID: 33525334
    [Abstract] [Full Text] [Related]

  • 24. Reduction of protein kinase MARK4 in the brains of experimental scrapie rodents and human prion disease correlates with deposits of PrP(Sc).
    Gong HS, Guo Y, Tian C, Xie WL, Shi Q, Zhang J, Xu Y, Wang SB, Zhang BY, Chen C, Liu Y, Dong XP.
    Int J Mol Med; 2012 Sep 28; 30(3):569-78. PubMed ID: 22692785
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The H187R mutation of the human prion protein induces conversion of recombinant prion protein to the PrP(Sc)-like form.
    Hosszu LL, Tattum MH, Jones S, Trevitt CR, Wells MA, Waltho JP, Collinge J, Jackson GS, Clarke AR.
    Biochemistry; 2010 Oct 12; 49(40):8729-38. PubMed ID: 20718410
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Selective neuronal targeting in prion disease.
    DeArmond SJ, Sánchez H, Yehiely F, Qiu Y, Ninchak-Casey A, Daggett V, Camerino AP, Cayetano J, Rogers M, Groth D, Torchia M, Tremblay P, Scott MR, Cohen FE, Prusiner SB.
    Neuron; 1997 Dec 12; 19(6):1337-48. PubMed ID: 9427256
    [Abstract] [Full Text] [Related]

  • 33. Molecular interaction between prion protein and GFAP both in native and recombinant forms in vitro.
    Dong CF, Wang XF, Wang X, Shi S, Wang GR, Shan B, An R, Li XL, Zhang BY, Han J, Dong XP.
    Med Microbiol Immunol; 2008 Dec 12; 197(4):361-8. PubMed ID: 18087720
    [Abstract] [Full Text] [Related]

  • 34. Prion infection: seeded fibrillization or more?
    Birkmann E, Riesner D.
    Prion; 2008 Dec 12; 2(2):67-72. PubMed ID: 19098436
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. The metabolism of glycosaminoglycans is impaired in prion diseases.
    Mayer-Sonnenfeld T, Zeigler M, Halimi M, Dayan Y, Herzog C, Lasmezas CI, Gabizon R.
    Neurobiol Dis; 2005 Dec 12; 20(3):738-43. PubMed ID: 15951190
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.